CureVac
CVAC
CVAC was delisted on the 5th of January, 2026.
0 hedge funds and large institutions have $0 invested in CureVac in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 57 closing their positions.
2.64% less ownership
Funds ownership: 2.64% → 0% (-2.6%)
100% less funds holding
Funds holding: 57 → 0 (-57)
100% less capital invested
Capital invested by funds: $26.6M → $0 (-$26.6M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 57
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$8.83M |
| 2 |
OBAM
ODDO BHF Asset Management
Paris,
France
|
-$2.94M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.48M |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
-$2.29M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.53M |
CVAC Hedge Fund Activity: Q1 2026 in Review
0 institutional investors reported a position in CureVac (CVAC) for Q1 2026, worth a combined $0 — down 100% from $26.6M a quarter earlier.
Sellers outnumbered buyers: 57 funds closed out of CVAC and 0 opened new positions — a net loss of 57 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $8.83M sold.
- 0 institutional investors held CureVac (CVAC) as of Q1 2026, down from 57 in Q4 2025.
- Funds reported $0 of CureVac stock for Q1 2026, down 100% quarter-over-quarter.
- 0 funds opened new CureVac positions in Q1 2026 and 57 closed out, a net change of -57 holders.
- The largest CureVac seller in Q1 2026 was BlackRock, an estimated $8.83M sold.
Based on aggregated 13F filings for Q1 2026.